Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

GKB Ophthalmics Ltd - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations , 2015

 Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in their meeting held on November 11, 2021, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there was no utilization of funds, during the quarter ended September 30, 2021. Enclosed please find the Statement as per the format, giving details of the same. Kindly take the information on records.
11-11-2021
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Considering And Taking On Record The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2021.

 GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2021 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021. Further, notice is hereby given with reference to the above meeting of the Board of Directors, that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, has been closed from October 01, 2021 till the completion of 48 hours after the declaration of the said financial results of the Company. The Trading Window shall now re-open on Monday, November 15, 2021. This communication has been sent to all the Directors and all the designated employees of the Company.
29-10-2021
Bigul

GKB Ophthalmics Ltd - 533212 - Intimation Of Submission Of Application For Reclassification Of Status Of Members Forming Part Of The Promoter And Promoter Group To Public Shareholders.

 Pursuant to Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations , 2015, we wish to inform you that the Company has made an application on October 26, 2021, for reclassification of certain shareholders forming part of the ' Promoter and Promoter Group' Category to ' Public Shareholders'. Kindly take the information on record.
26-10-2021
Bigul

GKB Ophthalmics Ltd - 533212 - Submission Of Minutes Of 39Th Annual General Meeting Of The Company Held On 28Th September, 2021.

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclose herewith a copy of the Minutes of the proceedings of the 39th Annual General Meeting of the Company, held on 28th September, 2021. Kindly acknowledge receipt of the same.
21-10-2021
Bigul

GKB OPHTHALMICS LTD. - 533212 - Shareholding for the Period Ended September 30, 2021

 GKB Ophthalmics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
19-10-2021
Bigul

GKB OPHTHALMICS LTD. - 533212 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pooja BicholkarDesignation :- Company Secretary and Compliance Officer
11-10-2021
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2021. Kindly acknowledge receipt of the same.
11-10-2021
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF), has purchased 10 equity shares on 30.09.2021, of the Company, on market. Additionally 20 shares were purchased on September 09, 2021, which were settled only on September 14, 2021. Copy of disclosure required under Regulation 7 (2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, is enclosed herewith. Copy of disclosure received from KrishnaGopal Gupta and Sons -HUF is also enclosed herewith. Please acknowledge and take the same on record.
04-10-2021
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF), has purchased 821 equity shares on 29.09.2021, of the Company, on market. Copy of disclosure required under Regulation 7 (2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, is enclosed herewith. Copy of disclosure received from KrishnaGopal Gupta and Sons -HUF is also enclosed herewith. Please acknowledge and take the same on record.
30-09-2021
Bigul

GKB Ophthalmics Ltd - 533212 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time and BSE Circular no. LIST/COMP/01/2019-20 dated April 02, 2019, regarding Trading Restriction Period, the 'Trading Window' for dealing/ trading in the shares of the Company shall remain closed from October 01, 2021, till the completion of 48 hours after the declaration of the financial results of the Company, for the quarter and half year ended September 30, 2021. Accordingly, all the Designated Persons of the Company and their immediate relatives are being intimated not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further, the date of Board Meeting at which the said results will be considered, shall be intimated in due course of time. Kindly take the information on record.
30-09-2021
Next Page
Close

Let's Open Free Demat Account